Big Pharma's Big Bet on America: What's Behind the Multi Billion Dollar Investment Spree? The pharmaceutical industry has announced a slew of multi billion dollar investments in the United States.
Global giants like Eli Lilly, Pfizer, and Johnson & Johnson are pledging billions to boost their U. S. presence, with some estimates suggesting that the total investment could top $500 billion.
These announcements seem like a welcome shot in the arm for the American economy, but scratch beneath the surface, and it becomes clear that there's more at play here than just business as usual.